Influenza viruses

Manual of Molecular and Clinical Laboratory Immunology: 7th edition

Volumn , Issue , 2022, Pages 691-699

  Katz, Jacqueline M ^a   Klimov, Alexander I ^a   Lindstrom, Stephen E ^a   Cox, Nancy J ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Influenza viruses; Microneutralization; Reverse transcriptase PCR(RT PCR); Serodiagnosis; Vaccination

Indexed keywords

EID: 79959719356     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1128/9781555815905.ch78     Document Type: Chapter

References (49)

1. Betts, R. F. 1995. Influenza virus, p. 1546-1567. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and Practice of Infectious Diseases. Churchill Livingstone Inc., New York, N.Y.
2. Bonner, A. B., K. W. Monroe, L. I. Talley, A. E. Klasner, and D. W. Kimberlin. 2003. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics 112:363-367.
3. Bright, B. A., M. J. Medina, X. Xu, G. Perez-Oronoz, T. R. Wallis, L. Povinelli, N. J. Cox, and A. I. Klimov. Increasing incidence of adamantane resistance among influenza A(H3N2) viruses, isolated globally from 1994 to 2004: a cause for concern. Lancet 366:1175-1181.
4. Brockstad, K. A., R. J. Cox, J. Olofsson, R. Johsson, and L. R. Haaheim. 1995. Parenteral influenza vaccination induces a rapid systemic and local immune response. J. Infect. Dis. 171:198-203.
5. Cazacu, A. C., S. E. Chung, J. Greer, and G. J. Demmler. 2004. Comparison of the Directigen Flu A+B membrane enzyme immunoassay with viral culture for rapid detection of influenza A and B viruses in respiratory specimens. J. Clin. Microbiol. 42:3707-3710.
6. Centers for Disease Control and Prevention. 2004. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. 53:1-39.
7. Claas, E. C. J., A. D. M. E. Osterhaus, R. van Beek, J. C. De Jong, G. F. Rimmelzwaan, D. A. Senne, S. Krauss, K. F. Shortridge, and R. G. Webster. 1998. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351:472-477.
8. Cooper, N. J., A. J. Sutton, K. R. Abrams, A. Wailoo, D. Turner, and K. G. Nicholson. 2003. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomized controlled trials. Br. Med. J. 326:1235-1239.
9. Cox, N. J., and K. Subbarao. 1999. Influenza. Lancet 354:1277-1282.
10. Ellis, J. S., D. M. Fleming, and M. C. Zambon. 1997. Multiplex reverse transcription-PCR for surveillance of influenza A and B viruses in England and Wales in 1995 and 1996. J. Clin. Microbiol. 35:2076-2082.
11. El-Madhun, A. S., R. J. Cox, A. Soreide, J. Olofsson, and L. R. Haaheim. 1998. Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination. J. Infect. Dis. 178:933-939.
12. Emery, S. L., D. D. Erdman, M. D. Bowen, B. R. Newton, J. M. Winchell, R. F. Meyer, S. Tong, B. T. Cook, B. P. Holloway, K. A. McCaustland, P. A. Rota, B. Bankamp, L. E. Lowe, T. G. Ksiazek, W. J. Bellini, and L. J. Anderson. 2004. Real-time reverse transcription- polymerase chain reaction assay for SARS-associated coronavirus. Emerg. Infect. Dis. 10:311-316.
13. Fouchier, R. A., T. M. Bestebroer, S. Herfst, L. Van Der Kemp, G. F. Rimmelzwaan, and A. D. M. E. Osterhaus. 2000. Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene. J. Clin. Microbiol. 38:4096-4101.
14. Fouchier, R. A., V. Munster, A. Wallensten, T. M. Bestebroer, S. Herfst, D. Smith, G. F. Rimmelzwaan, B. Olsen, and A. D. Osterhaus. 2005. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 79:2814-2822.
15. Fritz, R. S., F. G. Hayden, D. P Calfee, L. M. R. Cass, A. W. Peng, W. G. Alvord, W. Strober, and S. E. Straus. 1999. Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo- controlled trial of intravenous zanamivir treatment. J. Infect. Dis. 180:586-593.
16. Gerhard, W. 2001. The role of the antibody response to influenza virus infection. Curr Top. Microbiol. Immunol. 260:171-190.
17. Gubareva, L. V, L. Kaiser, and F. G. Hayden. 2000. Influenza virus neuraminidase inhibitors. Lancet 355:827-835.
18. Hampson, A. W. 1997. Surveillance for pandemic influenza. J. Infect. Dis. 176:S8-S13.
19. Hay, A. J. 1998. The virus genome and its replication, pp. 43-53. In K. G. Nicholson, R. G. Webster, and A. J. Hay (ed.), Textbook of Influenza. Blackwell Science Ltd., Oxford, United Kingdom.
20. Hayden, F. G., R. B. Belshe, R. D. Clover, A. J. Hay, M. G. Oakes, and W. Soo. 1989. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N. Engl. J. Med. 321:1696-1702.
21. Hayden, F. G., A. D. M. E. Osterhaus, J. J. Treanor, D. M. Fleming, F. Y. Aoki, K. G. Nicholson, A. M. Bohnen, H. M. Hirst, O. Keene, and K. Wightman. 1997. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. N. Engl. J. Med. 337:874-880.
22. Hayden, F. G., J. J. Treanor, R. S. Fritz, M. Lobo, R. F. Betts, M. Miller, N. Kinnersley, R. G. Mills, P. Ward, and S. E. Straus. 1999. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza. JAMA 282:1240-1246.
23. Herlocher, M. L., J. Carr, J. Ives, S. Elias, R. Truscon, N. Roberts, and A. S. Monto. 2002. Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets. Antivir. Res. 54:99-111.
24. Kaiser, L., C. Wat, T. Mills, P. Mahoney, P. Ward, and F. Hayden. 2003. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch. Intern. Med. 163:1667-1672.
25. Kendal, A. P., J. J. Skehel, and M. S. Pereira. 1982. Concepts and Procedures for Laboratory-Based Influenza Surveillance. Centers for Disease Control, Atlanta, Ga.
26. Kiso, M., K. Mitamura, Y. Sakai-Tagawa, K. Shiraishi, C. Kawakami, K. Kimura, F. G. Hayden, N. Sugaya, and Y. Kawaoka. 2004. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364:759-765.
27. Koopmans, M., B. Wilbrink, M. Conyn, G. Natrop, H. van der Nat, H. Vennema, A. Meijer, J. van Steenbergen, R. Fouchier, A. Osterhaus, and A. Bosman. 2004. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363:587-593.
28. Lamb, R. A., and R. M. Krug. 1996. Orthomyxoviridae: the viruses and their replication, pp. 1353-1395. In B. N. Fields, D. M. Knipe, and P M. Howley (ed.), Fields Virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
29. Lee, M. S., P. C. Chang, J. H. Shien, M. C. Cheng, and H. K. Shieh. 2001. Identification and subtyping of avian influenza viruses by reverse transcription-PCR. J. Virol. Methods 97:13-22.
30. Mackay, I. M., K. E. Arden, and A. Nitsche. 2002. Realtime PCR in virology. Nucleic Acids Res. 30:1291-1305.
31. McKimm-Breschkin, J. L. 2000. Resistance of influenza viruses to neuraminidase inhibitors-a review. Antivir. Res. 47:1-17.
32. Moriuchi, H., N. Katsushima, H. Nishimura, K. Nakamura, and Y. Numazaki. 1991. Community-acquired influenza C virus infection in children. J. Pediatr. 118:235-238.
33. Nicholson, K. G. 1998. Human influenza, pp. 219-264. In K. G. Nicholson, R. G. Webster, and A. J. Hay (ed.), Textbook of Influenza. Blackwell Science Ltd., Oxford, United Kingdom.
34. Osterhaus, A. D., G. F. Rimmelzwaan, B. E. Martina, T. M. Bestebroer, and R. A. Fouchier. 2000. Influenza B virus in seals. Science 288:1051-1053.
35. Peiris, M., K. Y. Yuen, C. W. Leung, K. H. Chan, P. L. Ip, R. W. Lai, W. K. Orr, and K. F. Shortridge. 1999. Human infection with influenza H9N2. Lancet 354:916-917.
36. Roberts, N. 2001. Treatment of influenza with neuraminidase inhibitors: virological implications. Philos. Trans. R. Soc. 356:1895-1897.
37. Rowe, T., R. A. Abernathy, J. Hu-Primmer, W. W. Thompson, X. Lu, W. Lim, K. Fukuda, N. J. Cox, and J. M. Katz. 1999. Detection of antibody to avian influenza A(H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 37:937-943.
38. Shiraishi, K., K. Mitamura, Y. Sakai-Tagawa, H. Goto, N. Sugaya, and Y. Kawaoka. 2003. High frequency of resistant viruses harboring different mutations in amantadine- treated children with influenza. J. Infect. Dis. 188:57-61.
39. Simonsen, L., K. Fukuda, L. B. Schonberger, and N. J. Cox. 2000. The impact of influenza epidemics on hospitalization. J. Infect. Dis. 181:831-837.
40. Spackman, E., D. A. Senne, T. J. Myers, L. L. Bulaga, L. P. Garber, M. L. Perdue, K. Lohman, L. T. Daum, and D. L. Suarez. 2002. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J. Clin. Microbiol. 40:3256-3260.
41. Stevenson, P. G., and P C. Doherty. 1998. Cell-mediated immune response to influenza virus, pp. 278-287. In K. G. Nicholson, R. G. Webster, and A. J. Hay (ed.), Textbook of Influenza. Blackwell Science Ltd., Oxford, United Kingdom.
42. Stone, B., J. Burrows, S. Schepetiuk, G. Higgins, A. Hampson, R. Shaw, and T. W. Kok. 2004. Rapid detection and simultaneous subtype differentiation of influenza A viruses by real time PCR. J. Virol. Methods 117:103-112.
43. Subbarao, K., A. Klimov, J. Katz, H. Regnery, W. Lim, H. Hall, M. Perdue, D. Swayne, C. Bender, J. Huang, M. Hemphill, T. Rowe, M. Shaw, X. Xu, K. Fukuda, and N. Cox. 1998. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279:393-396.
44. Uyeki, T. 2003. Influenza diagnosis and treatment in children. A review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr. Infect. Dis. J. 22:164-177.
45. Van Elden, L. J. R., M. Nihuis, P. Shipper, R. Schuurman, and A. M. van Loon. 2001. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J. Clin. Microbiol. 39:196-200.
46. Webster, R. G., W. J. Bean, O. T. Gorman, T. M. Chambers, and Y. Kawaoka. 1992. Evolution and ecology of influenza A viruses. Microbiol. Rev. 56:152-179.
47. Weinberg, G. A., D. D. Erdman, K. M. Edwards, C. B. Hall, F. J. Walker, M. R. Griffin, B. Schwartz, and the New Vaccine Surveillance Network Study Group. 2004. Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children. J. Infect. Dis. 189:706-710.
48. Wood, J. M., R. E. Gaines-Das, J. Taylor, and P. Chakraverty. 1994. Comparison of influenza serological techniques by international collaborative study. Vaccine 12:167-174.
49. Ziegler, T., H. Hall, A. Sanchez-Fauquier, W. C. Gamble, and N. J. Cox. 1995. Type- and subtype-specific detection of influenza viruses in clinical specimens by rapid culture assay. J. Clin. Microbiol. 33:318-321.